(Q37844655)

English

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation

scientific article published on 18 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

object named as

Vivien Béziat

2

0 references

Vincent Vieillard

11

object named as

Vincent Vieillard

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

9

object named as

Patrice Debré

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Stéphanie Nguyen

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Françoise Norol

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Madalina Uzunov

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Hélène Trebeden-Negre

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Nabih Azar

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Ali Boudifa

7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Dominique Bories

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Jean-Paul Vernant

10

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Nathalie Dhédin

12

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

18 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1769-1778

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

NK cell recognition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recogn

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Prospects for the use of NK cells in immunotherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Determinants of antileukemia effects of allogeneic NK cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03058.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2010.03058.X

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37844655&oldid=2020745719"